Benefits and challenges of teleconsultation service for non-communicable disease follow-up in public healthcare clinics in Malaysia: a qualitative study
- PMID: 37518911
Benefits and challenges of teleconsultation service for non-communicable disease follow-up in public healthcare clinics in Malaysia: a qualitative study
Abstract
Introduction: Teleconsultation gained popularity to provide safe medical care during the pandemic. However, literature on the sustainability of teleconsultation service at primary care beyond pandemic situations is scarce. This study aimed to determine the use of teleconsultation services for non-communicable disease (NCD) follow-up and explore the benefits and challenges of the service implementation during and beyond COVID-19 pandemic in Malaysia.
Materials and methods: An exploratory qualitative study was conducted using videoconferencing. Fourteen medical officers working in public primary healthcare clinics from various regions of Malaysia were chosen using purposive sampling process, and participants underwent a total of seven paired in-depth interview (IDI) sessions. IDIs were video recorded, transcribed and subjected to interpretive thematic analysis.
Results: The two main themes which emerged were the benefits and challenges of NCD teleconsultation service. Various categories relating to benefits of teleconsultation for NCD care are as follows: (1) Improved efficiency for patient care delivery (improved effectiveness, convenient, improved safety, better disease monitoring, patient empowerment) and (2) Benefits for Health Care Providers (improved healthcare and service delivery). Main challenges identified were as follows: (1) Challenges for Delivery of Care (Patients' adaptation in using teleconsultation service, Patients abusing the system, Poor digital literacy, No proper disease monitoring record), (2) Challenges for Health Care Providers (Lack of dedicated team and training, Higher workload and time-consuming) and (3) Challenges for Health Care System (Institutional policy, legal and regulatory weakness, Medical record documentation and prescription updates).
Conclusion: Optimisation of NCD patient healthcare delivery via teleconsultation is beneficial during and after pandemic. Targeted improvements to address current challenges are crucial to optimise its use beyond the pandemic period in the Malaysian public healthcare system.
Similar articles
-
An Online Survey of the Perceptions of Clinical and Non-Clinical Professionals on Healthcare for Non-Communicable Diseases and COVID-19 Measures During the Pandemic in Malaysia.Int J Public Health. 2023 May 25;68:1605861. doi: 10.3389/ijph.2023.1605861. eCollection 2023. Int J Public Health. 2023. PMID: 37304500 Free PMC article.
-
Use of telehealth: Evidence from French teleconsultation for women's healthcare, prior and during COVID-19 pandemic.Health Serv Manage Res. 2023 Aug;36(3):182-192. doi: 10.1177/09514848221115845. Epub 2022 Aug 4. Health Serv Manage Res. 2023. PMID: 35924385 Free PMC article.
-
Non-communicable disease (NCD) corners in public sector health facilities in Bangladesh: a qualitative study assessing challenges and opportunities for improving NCD services at the primary healthcare level.BMJ Open. 2019 Oct 7;9(10):e029562. doi: 10.1136/bmjopen-2019-029562. BMJ Open. 2019. PMID: 31594874 Free PMC article.
-
Non-communicable Disease Surveillance in Malaysia: An Overview of Existing Systems and Priorities Going Forward.Front Public Health. 2021 Jul 6;9:698741. doi: 10.3389/fpubh.2021.698741. eCollection 2021. Front Public Health. 2021. PMID: 34295873 Free PMC article. Review.
-
Service process factors affecting patients' and clinicians' experiences on rapid teleconsultation implementation in out-patient neurology services during COVID-19 pandemic: a scoping review.BMC Health Serv Res. 2022 Apr 22;22(1):534. doi: 10.1186/s12913-022-07908-4. BMC Health Serv Res. 2022. PMID: 35459134 Free PMC article.
Cited by
-
Long-Term Use of Metformin and Vitamin B12 Deficiency in Diabetes.Curr Drug Saf. 2025;20(3):258-270. doi: 10.2174/0115748863308106240816044733. Curr Drug Saf. 2025. PMID: 39206482 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical